Home
>
National Drug Code (NDC)
>
AGGRASTAT
AGGRASTAT - 25208-002-02 - (TIROFIBAN)
Drug Information of AGGRASTAT
| Product NDC: | 25208-002 |
| Proprietary Name: | AGGRASTAT |
| Non Proprietary Name: | TIROFIBAN |
| Active Ingredient(s): | 5 mg/100mL & nbsp; TIROFIBAN |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of AGGRASTAT
| Product NDC: | 25208-002 |
| Labeler Name: | Medicure International Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020913 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19980514 |
Package Information of AGGRASTAT
| Package NDC: | 25208-002-02 |
| Package Description: | 1 CONTAINER in 1 CARTON (25208-002-02) > 250 mL in 1 CONTAINER |
NDC Information of AGGRASTAT
| NDC Code | 25208-002-02 |
| Proprietary Name | AGGRASTAT |
| Package Description | 1 CONTAINER in 1 CARTON (25208-002-02) > 250 mL in 1 CONTAINER |
| Product NDC | 25208-002 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | TIROFIBAN |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19980514 |
| Marketing Category Name | NDA |
| Labeler Name | Medicure International Inc |
| Substance Name | TIROFIBAN HYDROCHLORIDE |
| Strength Number | 5 |
| Strength Unit | mg/100mL |
| Pharmaceutical Classes | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
